November 09, 2010 10:26
NPERC, Bayer to conduct joint research on biodegradable injection
Shanghai. November 9. INTERFAX-CHINA - The National Pharmaceutical Engineering Research Center (NPERC), a subsidiary of the Shanghai Institute of Pharmaceutical Industry (SIPI), has signed an agreement with German giant Bayer Schering Pharma AG to conduct joint research on a biodegradable injection drug delivery system, SIPI announced Nov. 8.
The announcement did not disclose the financial terms of the agreement.
NPERC is currently working on 10 different technologies for dosage preparation and drug delivery, including biodegradable microspheres, liposome preparations, a bioadhesive dosage form and an oral suspension sustained release system.
July 31, 2014
Russia and political and economic calendar: July 31
July 30, 2014
Poroshenko office: no need for peacekeepers, "least of all Russian"
Russia denies violating medium-range missile treaty with U.S.
SBU accuses Russia of fabricating evidence of causes of MH17 crash
PROBLEMS RELATED TO OBSERVANCE OF INF TREATY SHOULD BE DEALT WITH IN WORKING ORDER WITHOUT RESORTING TO 'MEGAPHONE DIPLOMACY' - RUSSIAN FOREIGN MINISTRY
RUSSIA HAS QUITE A FEW GRIEVANCES TO U.S. CONCERNING INF TREATY - RUSSIAN FOREIGN MINISTRY
"About 80% of Georgia-EU Association Agreement to take effect on Sept 1 - ministry
Voina art group leader detained in Italy with family (Part 2)
Moscow City Court finds four members of banned Islamic Liberation Party guilty (Part 4)
United Shipbuilding Corporation plays down U.S. sanctions
Russian budget to receive 210 bln rubles in dividends in 2014, up from 181 bln rubles in 2013
Russian stocks sharply higher on Wednesday despite declines on exchanges abroad
Main indexes of the Russia stock market for July 30